MedPath

Weight Changes in Parkinsonian Patients, Treated With Deep Brain Stimulation

Not Applicable
Completed
Conditions
Parkinson Disease
Interventions
Procedure: Deep brain stimulation
Registration Number
NCT00221793
Lead Sponsor
University Hospital, Bordeaux
Brief Summary

The aim of this trial is to verify that neurostimulated parkinsonian patients gain weight and to study its link with an energetic balance change.

Detailed Description

The aim of this trial is to verify that neurostimulated parkinsonian patients gain weight and to study its link with an energetic balance change.

Twenty parkinsonian patients will be randomised : the delay between inclusion and neurostimulation wil be lengthened 3 months for one group, compared to the second one. The energy expenditure, at rest and after ingestion of a test meal, will be compared between the group of patients that had been neurostimulated and the group whose intervention has been postponed. Weight changes, energy intake, leptin level, neurophysiological parameters will be compared between both groups, and the nature and repartition of the weight gain will be assessed in the neurostimulated group. An eventual link between motor factors, pharmacological factors, and gain weight will be studied.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Age between 35 and 70; male or female; parkinson disease, with levo dopa response (at least 30%); severe but stable incapacity; no dementia, no psychosis, no depression; normal brain scanner done during the last 2 years.
Exclusion Criteria
  • diabetes thyroid disease pacemaker coagulation troubles previous drug abuse

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Deep brain stimulationDeep Brain Stimulation of the Subthalamic Nucleus
2Deep brain stimulationLater Deep Brain Stimulation of the Subthalamic Nucleus
Primary Outcome Measures
NameTimeMethod
Measurement of energy expenditure with indirect calorimetry in open chamber: at rest in the morning, without 24h-dopaminergic treatment, and after dopaminergic treatment intake; and post prandial thermogenesis after a test meal.After surgery and at 3 months
Secondary Outcome Measures
NameTimeMethod
increase of energy intakeAt visit 1 and at 3 months
UDPRS scalebefore surgery and after 3 months
Weight gainAt visit 1 and at 3 months
cognitive and psychological assessmentsbefore surgery and after 3 months
leptin, glucose, insulin blood levelsAt visite 1 and at 3 months

Trial Locations

Locations (1)

Service de neurologie Hôpital Haut-Lévêque

🇫🇷

Pessac, France

© Copyright 2025. All Rights Reserved by MedPath